C8A p.Arg444His
c.1331G>A · rs143908758 · VCV789429
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1731 | likely benign |
|---|---|---|
| REVEL | 0.861 | moderately pathogenic-leaning |
| SaProt | LLR -5.50 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.8 | GERP 0.57, phastCons 0.99 |
| Regional constraint | o/e 1.08 | unconstrained · MANE · 63 kb · p 0.034 · regional, not allelic |
| Overall | ||
| CADD | 24.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.539% | 186 |
| European (non-Finnish)grpmax | 0.393% | 255 |
| Remaining individualsnot grpmax-eligible | 0.267% | 374 |
| South Asian | 0.26% | 384 |
| Admixed American | 0.22% | 455 |
| African / African-American | 0.128% | 782 |
| Middle Eastern | 0.099% | 1,010 |
| Ashkenazi Jewishnot grpmax-eligible | 0.0236% | 4,229 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- C8A
- Protein
- p.Arg444His
- Coding
- c.1331G>A
- MANE Select
- NM_000562
- dbSNP
- rs143908758
- Type
- single nucleotide variant
- Location
- chr1:56908064 (GRCh38)
- Gene constraint
- LOEUF 1.168 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 79.58 · 11 PDB
- Residue 444
- a UniProt-annotated variant site (in c8d1); the macpf domain; an α-helix
Disease context
type I complement component 8 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Immunodeficiency due to a late component of complement deficiency (Orphanet):
- Inheritance
- Autosomal recessive
Similar variants
- C8A p.Arg424Ter Pathogenic ★★ same condition
- C8A p.Arg498Ter Pathogenic/Likely pathogenic ★★ same condition
- C8A p.Tyr210Ter Pathogenic/Likely pathogenic ★★ same condition
- C8A p.Tyr384Ter Pathogenic/Likely pathogenic ★★ same condition
- C8A p.Ile441Val Uncertain significance ★★ ⚠ same condition
- C8A p.Lys57Thr Uncertain significance ★★ ⚠ same condition
- C8A p.Pro52Leu Uncertain significance ★★ ⚠ same condition
- C8A p.Ala36Glu Benign/Likely benign ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/c8a-p-arg444his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown